REGENERON PHARMACEUTICALS, INC. Selling, General and Administrative Expense
REGENERON PHARMACEUTICALS, INC. (REGN) reported Selling, General and Administrative Expense of $662.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2026-06-30 was $662.10M, a 4.40% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2026-03-31 was $647.70M, a 2.32% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2025-12-31 was $775.00M, a 2.17% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. selling, general and administrative expense for the quarter ending 2025-09-30 was $657.80M, a 7.92% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2025 was $2.70B, a 8.61% decline from fiscal 2024.
- REGENERON PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2024 was $2.95B, a 12.28% increase from fiscal 2023.
- REGENERON PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2023 was $2.63B, a 24.36% increase from fiscal 2022.
- REGENERON PHARMACEUTICALS, INC. selling, general and administrative expense for fiscal 2022 was $2.12B, a 15.95% increase from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $662.10M 10-Q · filed 2026-07-30 | $1.31B 10-Q · filed 2026-07-30 | $2.08B derived: sum of 3 quarters · filed 2026-07-30 | $2.74B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $647.70M 10-Q · filed 2026-04-29 | $1.42B derived: sum of 2 quarters · filed 2026-04-29 | $2.08B derived: sum of 3 quarters · filed 2026-04-29 | $2.71B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $775.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $1.43B derived: sum of 2 quarters · filed 2026-02-04 | $2.07B derived: sum of 3 quarters · filed 2026-07-30 | $2.70B 10-K · filed 2026-02-04 | ||||
| 2025-09-30 | $657.80M 10-Q · filed 2025-10-28 | $1.29B derived: sum of 2 quarters · filed 2026-07-30 | $1.93B 10-Q · filed 2025-10-28 | $2.72B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $634.20M 10-Q · filed 2026-07-30 | $1.27B 10-Q · filed 2026-07-30 | $2.06B derived: sum of 3 quarters · filed 2026-07-30 | $2.77B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $633.00M 10-Q · filed 2026-04-29 | $1.43B derived: sum of 2 quarters · filed 2026-04-29 | $2.14B derived: sum of 3 quarters · filed 2026-04-29 | $2.90B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $792.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $1.51B derived: sum of 2 quarters · filed 2026-02-04 | $2.27B derived: sum of 3 quarters · filed 2026-02-04 | $2.95B 10-K · filed 2026-02-04 | ||||
| 2024-09-30 | $714.40M 10-Q · filed 2025-10-28 | $1.47B derived: sum of 2 quarters · filed 2025-10-28 | $2.16B 10-Q · filed 2025-10-28 | $2.90B derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-06-30 | $758.80M 10-Q · filed 2025-08-01 | $1.45B 10-Q · filed 2025-08-01 | $2.19B derived: sum of 3 quarters · filed 2026-02-04 | $2.83B derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-03-31 | $689.00M 10-Q · filed 2025-04-29 | $1.43B derived: sum of 2 quarters · filed 2026-02-04 | $2.07B derived: sum of 3 quarters · filed 2026-02-04 | $2.72B derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2023-12-31 | $737.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $1.38B derived: sum of 2 quarters · filed 2026-02-04 | $2.03B derived: sum of 3 quarters · filed 2026-02-04 | $2.63B 10-K · filed 2026-02-04 | ||||
| 2023-09-30 | $640.50M 10-Q · filed 2024-10-31 | $1.29B derived: sum of 2 quarters · filed 2024-10-31 | $1.89B 10-Q · filed 2024-10-31 | $2.55B derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-06-30 | $652.00M 10-Q · filed 2024-08-01 | $1.25B 10-Q · filed 2024-08-01 | $1.91B derived: sum of 3 quarters · filed 2025-02-05 | $2.44B derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-03-31 | $601.10M 10-Q · filed 2024-05-02 | $1.26B derived: sum of 2 quarters · filed 2025-02-05 | $1.79B derived: sum of 3 quarters · filed 2025-02-05 | $2.27B derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2022-12-31 | $660.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $1.19B derived: sum of 2 quarters · filed 2025-02-05 | $1.67B derived: sum of 3 quarters · filed 2025-02-05 | $2.12B 10-K · filed 2025-02-05 | ||||
| 2022-09-30 | $529.10M 10-Q · filed 2023-11-02 | $1.01B derived: sum of 2 quarters · filed 2023-11-02 | $1.46B 10-Q · filed 2023-11-02 | $2.02B derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-06-30 | $476.30M 10-Q · filed 2023-08-03 | $926.30M 10-Q · filed 2023-08-03 | $1.49B derived: sum of 3 quarters · filed 2024-02-05 | $1.93B derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-03-31 | $450.00M 10-Q · filed 2023-05-04 | $1.01B derived: sum of 2 quarters · filed 2024-02-05 | $1.45B derived: sum of 3 quarters · filed 2024-02-05 | $1.87B derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2021-12-31 | $559.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | $1.00B derived: sum of 2 quarters · filed 2024-02-05 | $1.42B derived: sum of 3 quarters · filed 2024-02-05 | $1.82B 10-K · filed 2024-02-05 | ||||
| 2021-09-30 | $445.00M 10-Q · filed 2022-11-03 | $859.70M derived: sum of 2 quarters · filed 2022-11-03 | $1.27B 10-Q · filed 2022-11-03 | $1.57B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-06-30 | $414.70M 10-Q · filed 2022-08-03 | $820.30M 10-Q · filed 2022-08-03 | $1.12B derived: sum of 3 quarters · filed 2023-02-06 | $1.45B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-03-31 | $405.60M 10-Q · filed 2022-05-04 | $709.10M derived: sum of 2 quarters · filed 2023-02-06 | $1.04B derived: sum of 3 quarters · filed 2023-02-06 | $1.38B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2020-12-31 | $303.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-06 | $630.40M derived: sum of 2 quarters · filed 2023-02-06 | $978.70M derived: sum of 3 quarters · filed 2023-02-06 | $1.35B 10-K · filed 2023-02-06 | ||||
| 2020-09-30 | $326.90M 10-Q · filed 2021-11-04 | $675.20M derived: sum of 2 quarters · filed 2021-11-04 | $1.04B 10-Q · filed 2021-11-04 | $1.49B derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-06-30 | $348.30M 10-Q · filed 2021-08-05 | $715.60M 10-Q · filed 2021-08-05 | $1.17B derived: sum of 3 quarters · filed 2022-02-07 | $1.47B derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-03-31 | $367.30M 10-Q · filed 2021-05-06 | $819.10M derived: sum of 2 quarters · filed 2022-02-07 | $1.12B derived: sum of 3 quarters · filed 2022-02-07 | $1.42B derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2019-12-31 | $451.80M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-07 | $756.20M derived: sum of 2 quarters · filed 2022-02-07 | $1.05B derived: sum of 3 quarters · filed 2022-02-07 | $1.34B 10-K · filed 2022-02-07 | $1.83B 10-K · filed 2020-02-07 | |||
| 2019-09-30 | $304.40M 10-Q · filed 2020-11-05 | $419.90M 10-Q · filed 2019-11-05 | $599.00M derived: sum of 2 quarters · filed 2020-11-05 | $890.10M 10-Q · filed 2020-11-05 | $1.25B 10-Q · filed 2019-11-05 | $952.40M derived: sum of 4 quarters · filed 2021-02-08 | ||
| 2019-06-30 | $294.60M 10-Q · filed 2020-08-05 | $417.30M 10-Q · filed 2019-08-06 | $585.70M 10-Q · filed 2020-08-05 | $828.10M 10-Q · filed 2019-08-06 | $648.00M derived: sum of 3 quarters · filed 2021-02-08 | $1.02B derived: sum of 4 quarters · filed 2021-02-08 | ||
| 2019-03-31 | $291.10M 10-Q · filed 2020-05-05 | $410.80M 10-Q · filed 2019-05-07 | $353.40M derived: sum of 2 quarters · filed 2021-02-08 | $722.60M derived: sum of 3 quarters · filed 2021-02-08 | $1.09B derived: sum of 4 quarters · filed 2021-02-08 | |||
| 2018-12-31 | $62.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | $431.50M derived: sum of 2 quarters · filed 2021-02-08 | $796.30M derived: sum of 3 quarters · filed 2021-02-08 | $1.13B 10-K · filed 2021-02-08 | $1.56B 10-K · filed 2019-02-07 | |||
| 2018-09-30 | $369.20M 10-Q · filed 2019-11-05 | $369.23M 10-Q · filed 2018-11-06 | $734.00M derived: sum of 2 quarters · filed 2019-11-05 | $1.06B 10-Q · filed 2019-11-05 | $1.06B 10-Q · filed 2018-11-06 | $1.47B derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-06-30 | $364.80M 10-Q · filed 2019-08-06 | $364.88M 10-Q · filed 2018-08-02 | $695.60M 10-Q · filed 2019-08-06 | $695.65M 10-Q · filed 2018-08-02 | $1.11B derived: sum of 3 quarters · filed 2020-02-07 | $1.41B derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-03-31 | $330.80M 10-Q · filed 2019-05-07 | $330.77M 10-Q · filed 2018-05-03 | $740.68M derived: sum of 2 quarters · filed 2020-02-07 | $1.05B derived: sum of 3 quarters · filed 2020-02-07 | $1.35B derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | $409.88M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $716.65M derived: sum of 2 quarters · filed 2020-02-07 | $1.02B derived: sum of 3 quarters · filed 2020-02-07 | $1.32B 10-K · filed 2020-02-07 | $1.32B 10-K · filed 2018-02-08 | |||
| 2017-09-30 | $306.77M 10-Q · filed 2018-11-06 | $613.67M derived: sum of 2 quarters · filed 2018-11-06 | $910.52M 10-Q · filed 2018-11-06 | $1.24B derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-06-30 | $306.91M 10-Q · filed 2018-08-02 | $603.75M 10-Q · filed 2018-08-02 | $929.69M derived: sum of 3 quarters · filed 2019-02-07 | $1.20B derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-03-31 | $296.85M 10-Q · filed 2018-05-03 | $622.79M derived: sum of 2 quarters · filed 2019-02-07 | $892.83M derived: sum of 3 quarters · filed 2019-02-07 | $1.18B derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2016-12-31 | $325.94M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | $595.99M derived: sum of 2 quarters · filed 2019-02-07 | $888.02M derived: sum of 3 quarters · filed 2019-02-07 | $1.18B 10-K · filed 2019-02-07 | $1.18B 10-K · filed 2017-02-09 | |||
| 2016-09-30 | $270.05M 10-Q · filed 2017-11-08 | $562.08M derived: sum of 2 quarters · filed 2017-11-08 | $851.76M 10-Q · filed 2017-11-08 | $1.15B derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-06-30 | $292.04M 10-Q · filed 2017-08-03 | $581.72M 10-Q · filed 2017-08-03 | $876.67M derived: sum of 3 quarters · filed 2018-02-08 | $1.09B derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-03-31 | $289.68M 10-Q · filed 2017-05-04 | $584.63M derived: sum of 2 quarters · filed 2018-02-08 | $794.62M derived: sum of 3 quarters · filed 2018-02-08 | $969.21M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2015-12-31 | $294.95M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | $504.95M derived: sum of 2 quarters · filed 2018-02-08 | $679.53M derived: sum of 3 quarters · filed 2018-02-08 | $838.53M 10-K · filed 2018-02-08 | ||||
| 2015-09-30 | $209.99M 10-Q · filed 2016-11-04 | $384.58M derived: sum of 2 quarters · filed 2016-11-04 | $543.57M 10-Q · filed 2016-11-04 | $718.88M derived: sum of 4 quarters · filed 2016-11-04 | ||||
| 2015-06-30 | $174.59M 10-Q · filed 2016-08-04 | $333.58M 10-Q · filed 2016-08-04 | $508.89M derived: sum of 3 quarters · filed 2016-08-04 | $652.89M derived: sum of 4 quarters · filed 2016-08-04 | ||||
| 2015-03-31 | $158.99M 10-Q · filed 2016-05-05 | $334.30M derived: sum of 2 quarters · filed 2016-05-05 | $478.30M derived: sum of 3 quarters · filed 2016-05-05 | $575.03M derived: sum of 4 quarters · filed 2016-05-05 | ||||
| 2014-12-31 | $175.31M 10-Q · filed 2015-11-04 | $319.31M derived: sum of 2 quarters · filed 2015-11-04 | $416.04M derived: sum of 3 quarters · filed 2015-11-04 | $519.27M 10-K · filed 2017-02-09 | $504.75M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $144.00M 10-Q · filed 2015-11-04 | $149.75M 10-Q · filed 2014-11-04 | $240.73M derived: sum of 2 quarters · filed 2015-11-04 | $343.96M 10-Q · filed 2015-11-04 | $361.01M 10-Q · filed 2014-11-04 | $443.02M derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-06-30 | $96.73M 10-Q · filed 2015-08-04 | $102.41M 10-Q · filed 2014-08-05 | $199.96M 10-Q · filed 2015-08-04 | $211.26M 10-Q · filed 2014-08-05 | $299.02M derived: sum of 3 quarters · filed 2016-02-11 | $396.63M derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-03-31 | $103.23M 10-Q · filed 2015-05-07 | $108.85M 10-Q · filed 2014-05-08 | $202.29M derived: sum of 2 quarters · filed 2016-02-11 | $299.90M derived: sum of 3 quarters · filed 2016-02-11 | $372.36M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-12-31 | $99.06M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $196.67M derived: sum of 2 quarters · filed 2016-02-11 | $269.13M derived: sum of 3 quarters · filed 2016-02-11 | $346.39M 10-K · filed 2016-02-11 | $329.42M 10-K · filed 2014-02-13 | |||
| 2013-09-30 | $97.61M 10-Q · filed 2014-11-04 | $170.07M derived: sum of 2 quarters · filed 2014-11-04 | $247.33M 10-Q · filed 2014-11-04 | $305.07M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $72.46M 10-Q · filed 2014-08-05 | $149.72M 10-Q · filed 2014-08-05 | $207.46M derived: sum of 3 quarters · filed 2015-02-12 | $254.34M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $77.26M 10-Q · filed 2014-05-08 | $135.00M derived: sum of 2 quarters · filed 2015-02-12 | $181.88M derived: sum of 3 quarters · filed 2015-02-12 | $229.59M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | $57.74M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $104.62M derived: sum of 2 quarters · filed 2015-02-12 | $152.33M derived: sum of 3 quarters · filed 2015-02-12 | $210.75M 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | $46.88M 10-Q · filed 2013-11-05 | $94.59M derived: sum of 2 quarters · filed 2013-11-05 | $153.02M 10-Q · filed 2013-11-05 | $189.37M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-06-30 | $47.70M 10-Q · filed 2013-08-06 | $106.13M 10-Q · filed 2013-08-06 | $142.48M derived: sum of 3 quarters · filed 2014-02-13 | $175.40M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-03-31 | $58.43M 10-Q · filed 2013-05-03 | $94.78M derived: sum of 2 quarters · filed 2014-02-13 | $127.69M derived: sum of 3 quarters · filed 2014-02-13 | $152.28M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2011-12-31 | $36.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | $69.27M derived: sum of 2 quarters · filed 2014-02-13 | $93.85M derived: sum of 3 quarters · filed 2014-02-13 | $117.26M 10-K · filed 2014-02-13 | ||||
| 2011-09-30 | $32.92M 10-Q · filed 2012-10-24 | $57.50M derived: sum of 2 quarters · filed 2012-10-24 | $80.91M 10-Q · filed 2012-10-24 | $101.55M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | $24.59M 10-Q · filed 2012-07-25 | $48.00M 10-Q · filed 2012-07-25 | $68.64M derived: sum of 3 quarters · filed 2013-02-15 | $84.30M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-03-31 | $23.41M 10-Q · filed 2012-04-26 | $44.05M derived: sum of 2 quarters · filed 2013-02-15 | $59.71M derived: sum of 3 quarters · filed 2013-02-15 | $74.39M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2010-12-31 | $20.64M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $36.30M derived: sum of 2 quarters · filed 2013-02-15 | $50.98M derived: sum of 3 quarters · filed 2013-02-15 | $65.20M 10-K · filed 2013-02-15 | ||||
| 2010-09-30 | $15.66M 10-Q · filed 2011-10-27 | $30.34M derived: sum of 2 quarters · filed 2011-10-27 | $44.56M 10-Q · filed 2011-10-27 | $61.59M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-06-30 | $14.68M 10-Q · filed 2011-07-28 | $28.90M 10-Q · filed 2011-07-28 | $45.93M derived: sum of 3 quarters · filed 2012-02-21 | $58.77M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2010-03-31 | $14.22M 10-Q · filed 2011-05-03 | $31.25M derived: sum of 2 quarters · filed 2012-02-21 | $44.09M derived: sum of 3 quarters · filed 2012-02-21 | $55.73M derived: sum of 4 quarters · filed 2012-02-21 | ||||
| 2009-12-31 | $17.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-21 | $29.87M derived: sum of 2 quarters · filed 2012-02-21 | $41.50M derived: sum of 3 quarters · filed 2012-02-21 | $52.92M 10-K · filed 2012-02-21 | ||||
| 2009-09-30 | $12.84M 10-Q · filed 2010-10-28 | $24.47M derived: sum of 2 quarters · filed 2010-10-28 | $35.89M 10-Q · filed 2010-10-28 | |||||
| 2009-06-30 | $11.63M 10-Q · filed 2010-07-28 | $23.05M 10-Q · filed 2010-07-28 | ||||||
| 2008-12-31 | $48.88M 10-K · filed 2011-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |